CORRELATION OF TIMING AND CLINICAL BENEFIT FROM TREATMENT WITH PEMETREXED IN METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC)

    Authors

    N. H. Sadraei; C. Jones; A. Tan; P. Elson; T. Mekhail;N. Pennell

    Comments

    Authors: contact us about adding a copy of your work at [email protected]

    Abbreviated Journal Title

    J. Thorac. Oncol.

    Keywords

    non-small cell lung cancer; advanced stage; pemetrexed; Oncology; Respiratory System

    Journal Title

    Journal of Thoracic Oncology

    Volume

    6

    Issue/Number

    6

    Publication Date

    1-1-2011

    Document Type

    Meeting Abstract

    Language

    English

    First Page

    S1304

    Last Page

    S1305

    WOS Identifier

    WOS:000291769801166

    ISSN

    1556-0864

    Share

    COinS
     

    Accessibility Statement

    This item was created or digitized prior to April 24, 2027, or is a reproduction of legacy media created before that date. It is preserved in its original, unmodified state specifically for research, reference, or historical recordkeeping. In accordance with the ADA Title II Final Rule, the University Libraries provides accessible versions of archival materials upon request. To request an accommodation for this item, please submit an accessibility request form.